Baynes Roy D. bought NRIX
May 15, 2026 · Form 4 insider transaction
Baynes Roy D. bought 31,250 shares of Nurix Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,250
Price
$0.00
Total value
N/A
InsiderBaynes Roy D.
RoleDirector
SecurityDirector Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 15, 2026
Filing dateMay 15, 2026
Shares owned after31,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 15, 2027, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.